Navigation Links
Neurologix Announces First Quarter 2011 Financial Results
Date:5/13/2011

unts in thousands, except share and per share amounts)Three Months Ended
March  31,

For the period
February 12, 1999
(inception) through
March 31, 20112011

2010Revenues

$
-

$
-

$
-Operating expenses:Research and development

1,227

1,857

34,723General and administrative expenses

830

1,284

23,044Loss from operations

(2,057)

(3,141)

(57,767)Other (expense) income:Dividend, interest and other income

-

-

1,885Interest expense – related parties

(1,368)

-

(2,234)Change in estimated fair value of derivative financial instruments – warrants

1,343

(356)

(1,892)  Other (expense) income, net

(25)

(356)

(2,241)Net loss

(2,082)

(3,497)

$(60,008)Preferred stock dividends

(828)

(771)Net loss applicable to common stock

$(2,910)

$(4,268)Net loss applicable to common stock per share, basic and diluted

$(0.10)

$(0.15)Weighted average common shares outstanding, basic and diluted

27,918,148

27,865,010
'/>"/>

SOURCE Neurologix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. New Details Presented at the World Parkinson Congress on Neurologixs Successful Phase 2 Trial of Gene Therapy for Parkinsons Disease
2. Research Published in Science Translational Medicine Underscores Value of Depression Gene Therapy License Held by Neurologix
3. Neurologix Reports Third Quarter 2010 Financial Results
4. Neurologix Completes Additional $7 Million Financing
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , Sept. 2, 2015 Research ... addition of the "Medical Device Studies: Clinical ... conference to their offering. This ... are involved in gathering clinical evidence required for ... is required for all medical devices and the ...
(Date:9/2/2015)... , Sept. 2, 2015 Research and Markets ... "New EU Pharmacovigilance Legislation (London, UK - November ... The 15 new EU modules concerning Pharmacovigilance are ... is conducted in Europe . The ... modules and their requirements, examine how they overlap and ...
(Date:9/2/2015)... , Sept. 2, 2015 Demers Ambulances is ... Inc. as their new dealer for the states of ... Tennessee . "This will ... said Benoit Lafortune , Executive Vice-President for Demers Ambulances. ... Mississippi and Alabama , ...
Breaking Medicine Technology:Medical Device Studies: Clinical Evidence Course - London, UK - November 10-11, 2015 2Demers Ambulances has named Emergency Equipment Professionals (EEP) Inc. as their dealer for the states of MS, AL and TN 2
... GSK ) today announced that the United ... for PROMACTA® (eltrombopag), an oral tablet that can raise ... chronic immune (idiopathic) thrombocytopenic purpura (ITP) who have had ... PROMACTA initially received FDA orphan drug designation ...
... Therapeutics LLC ("Deston") announced today that it is currently exploring ... Auralgan Otic Solution ("Auralgan") by the Federal Government and that ... drug product. "Despite the recent actions by ... and effective treatment for ear pain and inflammation," said David ...
Cached Medicine Technology:FDA Grants Full Approval for PROMACTA® (eltrombopag) for Treatment of Rare Blood Disorder 2FDA Grants Full Approval for PROMACTA® (eltrombopag) for Treatment of Rare Blood Disorder 3FDA Grants Full Approval for PROMACTA® (eltrombopag) for Treatment of Rare Blood Disorder 4Deston Therapeutics Stands By Safety and Efficacy of Auralgan After FDA Action 2Deston Therapeutics Stands By Safety and Efficacy of Auralgan After FDA Action 3Deston Therapeutics Stands By Safety and Efficacy of Auralgan After FDA Action 4
(Date:9/2/2015)... KY (PRWEB) , ... September 02, 2015 , ... Ericson ... the CDI Education Director for HCPro and Associate Director of Education for the Association ... CDI, Advancing CDI and ICD-10 for CDI Boot Camps. She serves as a CDI ...
(Date:9/2/2015)... ... September 02, 2015 , ... The 2015 China Overseas ... investment and business conference will be hosted at five star Beijing Kunlun Hotel ... networking conference will feature leading EB-5 industry professionals and Chinese private equity partners ...
(Date:9/2/2015)... Minneapolis, MN (PRWEB) , ... September 02, 2015 ... ... is commercializing products for the upper extremity surgical market, announced today that more ... instrument for trigger releases in the hand. Plus, nearly 70 of these ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... On September ... to attend doTERRA’s annual convention, the largest single-company convention to date for the state ... and look forward to a tremendous event,” states David Stirling, doTERRA CEO. “One of ...
(Date:9/2/2015)... ... September 02, 2015 , ... The payroll conference ... days of payroll education covering legislative updates, including unemployment, global payroll best practices, ... representatives from Ceridian, Ultimate Software, the American Payroll Association, Barnett Associates, and the ...
Breaking Medicine News(10 mins):Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 2Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 3Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 4Health News:The 2015 China Overseas Investment and Entrepreneurship Summit (COIES) Announced 2Health News:Trigger Tome Surpasses 600 Successful Patient Procedures 2Health News:doTERRA to Host the Largest Single-Company Convention in the State of Utah 2Health News:23rd Annual NJ Statewide Payroll Conference in Vernon, NJ at the Minerals Hotel on October 15-16, 2015 2
... indeed a ‘ubiquitous’ festival, as it is celebrated throughout the ... 26 million Indian homes.// The joys of the season is ... making the most of the special bargains and discounts of ... the celebration. Plans are afoot in great enthusiasm as homes ...
... The surprising structure and properties of a protein responsible for ... it binds its target RNA// -- are described by researchers ... is an essential nutrient, and defects in uptake and metabolism ... a variety of diseases and disorders, including heart disease, arthritis ...
... Agricultural Research Service (ARS) funded research suggest that berry extracts ... found that laboratory animals, which were fed berry extracts and ... damage to brain function. ,Three groups ... for about three months. The control group was fed a ...
... Health plans, school girls as young as 12 could ... cause cervical cancer//. Researchers have found that the Human ... of cervical cancer, which kills around 1,000 women a ... the human papilloma virus (HPV) before they become sexually ...
... (AL) on Saturday voiced concern on the developments regarding the ... Libyan children with the HIV/AIDS virus//. AL also issued an ... ,The AL also expressed full sympathy underlining the ... order to curb the consequences of this "painful human catastrophe". ...
... (FDA) is expected to announce soon the results of its ... some species of cloned animals. ,Two experts ... Agriculture Policy are available to media to comment on the ... safety of consuming meat and milk from cloned animals. ...
Cached Medicine News:Health News:Come Apart and Rest Awhile – It’s Christma 2Health News:Come Apart and Rest Awhile – It’s Christma 3Health News:Structure of Iron Regulatory Protein-RNA Complex Solved 2
... Vascular Graft, the newest vascular graft offering ... leader in vascular surgical products for more ... reducing kinking and compression problems that ... graft provides all of the benefits of ...
... rasping necessary in cruciate ligament reconstruction procedures ... bone surface. This condition, if not rectified ... cruciate replacement. The GORE SMOOTHER Crucial Tool ... procedures. The tool functions as both a ...
Vikingselect™ Intra-Operative Monitoring (IOM)....
... system has been designed by practicing ... of the ever changing and demanding ... analyzing data from multiple modalities, including: ... and multiple patients at multiple sites. ...
Medicine Products: